Biohaven Pharma (BHVN) and Pfizer (PFE) announce strategic collaboration for the global commercialization of NURTEC ODT outside the United States

Go back to Biohaven Pharma (BHVN) and Pfizer (PFE) announce strategic collaboration for the global commercialization of NURTEC ODT outside the United States
(NYSE: BHVN) Delayed: 15.18 -0.32 (2.06%)
Previous Close $15.50    52 Week High
Open $15.15    52 Week Low
Day High $15.80    P/E N/A 
Day Low $15.04    EPS
Volume 344,686       

(NASDAQ: PRTG) Delayed: 6.81 --0 (-0%)
Previous Close $6.81    52 Week High
Open $6.81    52 Week Low
Day High $6.81    P/E N/A 
Day Low $6.81    EPS
Volume 2,270